Ondine Biomedical has suspended trading to raise new investment following successful phase III trial results for its Steriwave nasal disinfection product, which reduced surgical site infections by 40.5%. The funds will support publishing trial results, preparing a New Drug Application to the FDA, and expanding sales in authorized markets like Canada, the UK, and Mexico. The company plans to meet with the FDA in early 2027 and file mid-year, while also strengthening its management team. Recent commercial wins include new hospital partnerships in Scotland and Mexico.
Ondine Biomedical's recent trading pause to raise investment follows its positive phase III trial results. For readers following the health sector, here is Pluang's market snapshot as of Sep 30, 2026 14:41 WIB: out of 100 priced health-sector US stocks tradable on Pluang, 59 rose and 37 fell. Notable movers include ADPT at USD 29.10 with a 1-day change of +2.07% and 100% buy order activity, XRAY at USD 9.46 up 1.94%, and INO at USD 1.13 up 1.80%.
Victory Capital Holdings is rated Strong Buy due to robust net inflows, accretive acquisitions, and strong earnings growth. The acquisition of First Eagle is expected to boost 2027 EPS by 35%, increase assets under management to $570 billion, and rai...
Ethereum is trading around $2,680, stuck below a critical resistance zone of $2,710-$2,720, with about 125,000 ETH moved to exchanges signaling increased selling pressure. US spot Ethereum ETF inflows sharply dropped from $269.9 million to $17.1 mill...
The State Street SPDR ICE Preferred Securities ETF (PSK) primarily holds fixed-rate, perpetual preferred securities, making it highly sensitive to interest rate changes and long-duration credit risks. It closely tracks long-term corporate credit ETFs...
The Direxion Daily Technology Bull 3X ETF (TECL) is rated Buy due to expected strong growth in AI infrastructure and overall technology sector outperformance. Despite challenges like inflation and macroeconomic risks, the technology sector, especiall...
Bitcoin remained stable around $83,453 after peaking above $85,000 over the weekend, supported by easing crude oil prices and reduced Treasury bond market volatility. The cryptocurrency has surged 43.1% in Q3 2026, its strongest quarterly gain since ...
